Michael Merson writes on “Harnessing the passion for global health at Duke” in the Duke University Chronicle.
An international team of researchers has identified three gene variants in the DNA of 486 people infected with HIV that appear to have helped some of the patients fight off the virus and delay the onset of full-blown AIDS. The researchers expect the new findings to aid the search for an HIV vaccine that would work by boosting the protective effects of one or more of these genes, and help the body’s own immune system overcome an infection. It took the international genetics team, called EuroCHAVI, pooling their cohorts of carefully selected patients and using the latest in genome-wide screening technology, 18 months to discover the three genes, that together greatly increase our knowledge of why patients differ in how well they can control the virus that causes AIDS.
When Duke neurosurgeon Michael Haglund, M.D., Ph.D., visited New Mulago Hospital in Kampala, Uganda last January, he was astounded at what he saw.
Caitlin Milligan’s blog describes her experience in a voluntary counseling and testing clinic in Edgerton, Kenya. She was part of a team funded by DukeEngage.
What do the French Family Science Center, DukeEngage and University HIV/AIDS research centers have in common? Melinda Gates and global health.
Nov. 1, Michael Merson became the first director of the newly formed Global Health Institute, a year after a University steering committee recommended the institute’s formation.
Buried in the bowels of Trent Drive Hall, amid scaffolding and buckets of paint, lies the start of Duke’s $30-million Global Health Institute. Although the beginning may not be glamorous-with only three staff members and a handwritten paper sign scotch-taped to the wall bearing its name-newly appointed director Michael Merson has grand ambitions for the institute, both in Durham and across the globe.